Transplantation of livers from HBc Ab positive donors into HBc Ab negative recipients: A strategy and preliminary results

Clinical Transplantation

Volumn 15, Issue SUPPL. 6, 2001, Pages 55-58

  Loss, George E ^a   Mason, Andrew L ^a   Blazek, Jamie ^a   Dick, Debbie ^a   Lipscomb, Jeane ^a   Guo, Linsheng ^a   Perrillo, Robert P ^a   Eason, James D ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Hepatitis B core antibody; Hepatitis B immune globulin; Hepatitis B virus; Lamivudine; Liver transplantation; Marginal organ donors

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA;

ADULT; AGED; ALLOGRAFT; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ERADICATION THERAPY; FEMALE; FOLLOW UP; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNIZATION; LIVER; LIVER BIOPSY; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MALE; ORGAN DONOR; POLYMERASE CHAIN REACTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECIPIENT; SAMPLE; SERUM;

ADULT; AGED; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VACCINES; HUMANS; LAMIVUDINE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TISSUE DONORS;

EID: 0035159525     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2001.0150s5055.x     Document Type: Article

References (11)

1. Serologic evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft
2. The risk of transmission of hepatitis from HBs Ag (-), HBc Ab (+), HBIgM (-) organ donors
3. Transmission of hepatitis B virus from hepatitis B antibody-positive donors in living related liver transplants
4. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen
5. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
6. Molecular basis for persistent hepatitis B virus in the liver after clearance of serum HBs Ag
7. Detection of hepatitis B virus in serum using amplification of viral DNA by means of the polymerase chain reaction
8. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen
9. Latent hepatitis B infection in healthy individuals with antibodies to hepatitis B core antigen
10. Can hepatitis B core antibody positive livers be used safely for transplantation: Hepatitis B virus detection in the liver of individuals who are hepatitis B core antibody positive
11. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors